<?xml version="1.0" encoding="UTF-8"?>
<ref id="B132-pharmaceuticals-13-00096">
 <label>132.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McIntyre</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Caffe</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Michalak</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Reid</surname>
    <given-names>J.L.</given-names>
   </name>
  </person-group>
  <article-title>Losartan, an orally active angiotensin (AT1) receptor antagonist: A review of its efficacy and safety in essential hypertension</article-title>
  <source>Pharmacol. Ther.</source>
  <year>1997</year>
  <volume>74</volume>
  <fpage>181</fpage>
  <lpage>194</lpage>
  <pub-id pub-id-type="doi">10.1016/S0163-7258(97)82002-5</pub-id>
  <pub-id pub-id-type="pmid">9336021</pub-id>
 </element-citation>
</ref>
